ANXA10 and neoplasm: This aPKC-ANXA10-SREBP2 axis establishes a paradigm for metabolic reprogramming, which provides potential opportunities for therapeutic intervention and prevention in the context of serrated mCRC, a very aggressive type of neoplasia affecting a large proportion of patients with poor prognosis and in need of more tailored and efficient therapies.